We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
A gene therapy that could provide a permanent cure for sickle cell disease continues to show success through a third wave of patients, researchers report.
Transfusions with fresh red blood cells are not any better than older red blood cells at reducing the risk of organ failure or death in critically ill children, a new study says.
For critically ill pediatric patients, the incidence of new or progressive multiple organ dysfunction syndrome does not differ with the transfusion of fresh or standard-issue red blood cells ...
Researchers from the University of Bristol and NHS Blood and Transplant have managed to perfect a technique whereby it is possible to manufacture red blood cells to higher quantities than previously.